Dr. Arvind Agarwal

Srihari Naidu is an Interventional Cardiologist in Valhalla, New York. Dr. Naidu is highly rated in 11 conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Embolectomy.

An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is highly rated in 18 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Percutaneous Coronary Intervention (PCI).

Giora Weisz, MD, is an Associate Professor of Medicine at Columbia University Irving Medical Center and serves as the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hudson Valley Hospital. He graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel, and completed his residency in internal medicine and cardiology fellowship at the Carmel Medical Center in Haifa, Israel. Dr. Weisz finished his interventional cardiology training at Lenox Hill Hospital in New York.As an interventional cardiologist, Dr. Weisz focuses on current and innovative technologies. His expertise includes novel robotic-enhanced coronary interventions, with a special emphasis on navigation and positioning technologies. He also has a keen interest in the management of incomplete revascularization, novel intravascular imaging, and strategies for preventing contrast-induced nephropathy. Dr. Weisz is highly rated in 11 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.